Oddo BHF Asset Management Sas Purchases Shares of 15,784 McKesson Co. (NYSE:MCK)

Oddo BHF Asset Management Sas bought a new stake in McKesson Co. (NYSE:MCK - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,784 shares of the company's stock, valued at approximately $7,804,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MCK. Miracle Mile Advisors LLC raised its position in shares of McKesson by 55.8% in the second quarter. Miracle Mile Advisors LLC now owns 874 shares of the company's stock worth $510,000 after acquiring an additional 313 shares during the period. Stanley Laman Group Ltd. increased its stake in McKesson by 2.7% during the 2nd quarter. Stanley Laman Group Ltd. now owns 9,392 shares of the company's stock worth $5,485,000 after buying an additional 247 shares in the last quarter. Everpar Advisors LLC acquired a new position in shares of McKesson during the second quarter valued at approximately $243,000. Unique Wealth LLC boosted its stake in shares of McKesson by 16.9% in the second quarter. Unique Wealth LLC now owns 1,390 shares of the company's stock worth $812,000 after acquiring an additional 201 shares during the last quarter. Finally, TCW Group Inc. increased its position in shares of McKesson by 16.7% during the second quarter. TCW Group Inc. now owns 168,729 shares of the company's stock worth $98,544,000 after purchasing an additional 24,178 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company's stock.

Insider Transactions at McKesson

In other McKesson news, EVP Leann B. Smith sold 579 shares of the business's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $602.81, for a total transaction of $349,026.99. Following the sale, the executive vice president now directly owns 1,443 shares in the company, valued at approximately $869,854.83. The trade was a 28.64 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.11% of the company's stock.

McKesson Stock Performance

MCK stock traded down $2.71 during trading on Friday, hitting $576.58. The stock had a trading volume of 508,631 shares, compared to its average volume of 816,910. McKesson Co. has a 1-year low of $431.35 and a 1-year high of $637.51. The company's 50 day moving average price is $562.18 and its two-hundred day moving average price is $562.53. The stock has a market cap of $73.19 billion, a price-to-earnings ratio of 29.98, a price-to-earnings-growth ratio of 1.25 and a beta of 0.49.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 EPS for the quarter, topping analysts' consensus estimates of $6.88 by $0.19. The business had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business's revenue for the quarter was up 21.3% on a year-over-year basis. During the same period in the prior year, the firm posted $6.23 EPS. As a group, sell-side analysts forecast that McKesson Co. will post 32.73 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.49%. McKesson's dividend payout ratio is presently 14.71%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Evercore ISI raised their target price on shares of McKesson from $560.00 to $680.00 and gave the stock an "outperform" rating in a research note on Thursday, November 7th. Wells Fargo & Company increased their target price on McKesson from $535.00 to $641.00 and gave the stock an "equal weight" rating in a research note on Friday. Citigroup increased their price objective on McKesson from $630.00 to $713.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of McKesson from $623.00 to $579.00 and set a "buy" rating on the stock in a research note on Wednesday, September 25th. Finally, Baird R W upgraded shares of McKesson from a "hold" rating to a "strong-buy" rating in a report on Thursday, November 7th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, McKesson has an average rating of "Moderate Buy" and an average price target of $643.43.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.